An analysis of data from a nationwide health survey reveals “concerning” disparities in human papillomavirus (HPV) vaccine uptake among US adults aged 27 to 45 years.
‘Concerning’ disparities in HPV vaccine uptake among US adults, with men and Hispanic people among those least protected
